M Kelly Nicholas - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Neuro-Oncology Advances|August 9, 2023

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.

Neuro-Oncology|February 11, 2004

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium studyVinay K Puduvalli, W K Alfred Yung, Kenneth R Hess, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Neuro-Oncology Advances|August 9, 2023

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.

Neuro-Oncology|February 11, 2004

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, W K A Yung, Kurt A Jaeckle, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium studyVinay K Puduvalli, W K Alfred Yung, Kenneth R Hess, et al.

Pageof 3